Virtual clinical trial based on outcome modeling with iteratively redistributed extrapolation data
- PMID: 36947353
- DOI: 10.1007/s12194-023-00715-4
Virtual clinical trial based on outcome modeling with iteratively redistributed extrapolation data
Abstract
Virtual clinical trials (VCTs) can potentially simulate clinical trials on a computer, but their application with a limited number of past clinical cases is challenging due to the biased estimation of the statistical population. In this study, we developed ExMixup, a novel training technique based on machine learning, using iteratively redistributed extrapolated data. Information obtained from 100 patients with prostate cancer and 385 patients with oropharyngeal cancer was used to predict the recurrence after radiotherapy. Model performance was evaluated by developing outcome prediction models based on three types of training methods: training with original data (baseline), interpolation data (Mixup), and interpolation + extrapolation data (ExMixup). Two types of VCTs were conducted to predict the treatment response of patients with distinct characteristics compared to the training data obtained from patient cohorts categorized under risk classification or cancer stage. The prediction models developed with ExMixup yielded concordance indices (95% confidence intervals) of 0.751 (0.719-0.818) and 0.752 (0.734-0.785) for VCTs on the prostate and oropharyngeal cancer datasets, respectively, which significantly outperformed the baseline and Mixup models (P < 0.01). The proposed approach could enhance the ability of VCTs to predict treatment results in patients excluded from past clinical trials.
Keywords: Extrapolation data; Outcome modeling; Outcome prediction; Radiotherapy; Virtual clinical trial.
© 2023. The Author(s), under exclusive licence to Japanese Society of Radiological Technology and Japan Society of Medical Physics.
References
-
- Cante D, et al. Moderately hypofractionated radiotherapy with simultaneous integrated boost in prostate cancer: a comparative study with conventionally fractionated radiation. J Oncol. 2020;2020:5–10. https://doi.org/10.1155/2020/3170396 . - DOI
-
- Lee BM, Chang JS, Kim SY, Keum KC, Suh CO, Kim YB. Hypofractionated radiotherapy dose scheme and application of new techniques are associated to a lower incidence of radiation pneumonitis in breast cancer patients. Front Oncol. 2020;10(February):1–9. https://doi.org/10.3389/fonc.2020.00124 . - DOI
-
- Shen J, et al. Hypofractionated volumetric- modulated arc radiotherapy for patients with non-small-cell lung cancer not suitable for surgery or conventional chemoradiotherapy or SBRT. 2021;11(June):1–8. https://doi.org/10.3389/fonc.2021.644852 .
-
- Zhang Z, et al. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 2020;5(1). https://doi.org/10.1038/s41392-020-00213-8 .
-
- Nguyen TK, Nguyen EK, Warner A, Louie AV, Palma DA. Failed randomized clinical trials in radiation oncology: what can we learn? Int J Radiat Oncol Biol Phys. 2018;101(5):1018–24. https://doi.org/10.1016/j.ijrobp.2018.04.030 . - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous